ZEALAND PHARMA A/S earnings
Annual earnings per share (DKK per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2026 | 2026-06-30 | DKK 49.58 | DKK 50.00 | 2026-09-02 13:20:35.560704 |
| 2025 | 2025-06-30 | DKK 100.65 | DKK 102.39 | 2026-09-02 13:20:35.560704 |
Revenue & profit (DKK)
| Concept | 2026 | 2025-12-31 | 2025-06-30 |
|---|---|---|---|
| Revenue | DKK 4.53B | — | DKK 9.10B |
| Profit for the year | DKK 3.52B | — | DKK 7.24B |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in ZEALAND PHARMA A/S's ESEF annual reports (source:
filings.xbrl.org).
Figures are in DKK, as reported. Not investment advice.